$21.5 million in funding will be used to expand its existing roster of digitally-guided therapy solutions.
A decisive moment in lung cancer treatment is nearing
Impact of putting access to medicine at the core of pharma businesses.
Ingenious low-cost solutions to healthcare problems in the developing world can inspire change in global healthcare.
NHS England will be able to control cost impact of NICE decisions more directly.
Can medical-grade wearables provide efficient, patient-friendly, and cost-effective solutions in an ever-changing healthcare environment?
Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.